Introduction: The conservation of health products is critical, as they are sensitive to environmental conditions such as temperature, light, and freezing. Their storage and transport therefore require strict temperature controls [1]. Benin, like most West African countries, faces major challenges in managing the cold chain for health products, an issue that is critical to ensuring the quality and availability of vital medicines, particularly in low-income countries. Our study aimed to identify the factors associated with cold chain performance for health products in health facilities in southern Benin in 2025. Methods: We conducted an analytical cross-sectional study in 120 health facilities drawn from 17 health zones across 6 departments in southern Benin. A proportional random probability sampling method was used to select these health facilities. The association between good cold chain performance and its potential determinants was analyzed using multiple logistic regression, after adjustment for the variables included in the model. The significance threshold was set at 0.05, with a 95% confidence interval (95% CI), using Epi Info software version 7.2.2. Results: The mean performance score was 21.98 ± 4.10, with values ranging from 11 to 32, and a mode of 23. Staff training on cold chain management (aOR [95% CI] = 4.06 [1.01 - 16.35], p = 0.0485), refrigerator age ≤ 5 years (aOR [95% CI] = 4.10 [1.33 - 12.63], p = 0.0168), availability of a preventive maintenance schedule (aOR [95% CI] = 7.72 [1.78 - 33.47], p = 0.0084), and availability of a dedicated budget line (aOR [95% CI] = 5.98 [1.97 - 18.12], p = 0.0014) were statistically associated with good cold chain performance for health products. Conclusion: The results show that cold chain performance relies on a balance between human competencies, equipment quality, structured maintenance organization, and sustainable financing. The coordinated implementation of continuous staff capacity building, the progressive renewal of aging equipment, the institutionalization of preventive maintenance, and the securing of dedicated financial resources will help sustainably improve the performance of health facilities and strengthen the safety of vaccination and public health programs.
References
[1]
World Health Organization (2020) Les produits de santé thermosensibles dans la cha?ne du froid du Programme élargi de vaccination. https://iris.who.int/server/api/core/bitstreams/6d0eecf5-f9b0-40de-81b2-41866baec585/content
[2]
Swisslog Healthcare (2026) What Is a Cold Chain? Definition and Importance in Healthcare. https://www.swisslog-healthcare.com/fr-fr/societe/blog/qu-est-ce-qu-une-chaine-du-froid
[3]
Logiphar (2025) Mastering the Cold Chain: Challenges and Best Practices. Logiphar. https://www.logiphar.com/maitriser-la-chaine-du-froid-enjeux-et-bonnes-pratiques/
[4]
Scott, G.Y., Aborode, A.T., Adesola, R.O., Khan, M., Elebesunu, E.E., Oluwaseun, A.A., et al. (2025) Enhancing Vaccine Quality and Accessibility: Strategies for Efficient Storage and Distribution in Resource-Constrained Environment. Outbreak Management and Response, 1, Article ID: 2443439. https://doi.org/10.1080/29947677.2024.2443439
[5]
Maureen, I.A., Ugwu, D.C., Egwuenu, A., Muhammad, F.S. and David, I. (2026) Challenges and Innovations of Vaccine Cold Chain Distribution in Developing Countries: A Narrative Review. International Journal of Research and Scientific Innovation, 12, 1404-1417. https://doi.org/10.51244/ijrsi.2025.12120121
[6]
ECOWAS (2026) P08—Health Infrastructure and Equipment. West African Health Organisation.
[7]
Hanson, C.M., George, A.M., Sawadogo, A. and Schreiber, B. (2017) Is Freezing in the Vaccine Cold Chain an Ongoing Issue? a Literature Review. Vaccine, 35, 2127-2133. https://doi.org/10.1016/j.vaccine.2016.09.070
[8]
WHO (2026) Effective Vaccine Management (EVM). https://www.who.int/teams/immunization-vaccines-and-biologicals/essential-programme-on-immunization/supply-chain/effective-vaccine-management-(evm)
[9]
Brison, M. and LeTallec, Y. (2017) Transforming Cold Chain Performance and Management in Lower-Income Countries. Vaccine, 35, 2107-2109. https://doi.org/10.1016/j.vaccine.2016.11.067
[10]
Government of the Republic of Benin (2026) Mapping of Benin’s 34 Health Zones for Patient Safety: More than 150 Managers Trained and Deployed. https://www.gouv.bj/article/2975/
Yakum, M.N., Ateudjieu, J., Walter, E.A. and Watcho, P. (2015) Vaccine Storage and Cold Chain Monitoring in the North West Region of Cameroon: A Cross Sectional Study. BMC Research Notes, 8, Article No. 145. https://doi.org/10.1186/s13104-015-1109-9
[13]
World Health Organization (2015) How to Monitor Temperatures in the Vaccine Supply Chain. https://iris.who.int/server/api/core/bitstreams/87e73054-8634-4c32-b7a4-783ef105be19/content
[14]
Zipursky, S., Djingarey, M.H., Lodjo, J., Olodo, L., Tiendrebeogo, S. and Ronveaux, O. (2014) Benefits of Using Vaccines Out of the Cold Chain: Delivering Meningitis a Vaccine in a Controlled Temperature Chain during the Mass Immunization Campaign in Benin. Vaccine, 32, 1431-1435. https://doi.org/10.1016/j.vaccine.2014.01.038
[15]
Ashok, A., Brison, M. and LeTallec, Y. (2017) Improving Cold Chain Systems: Challenges and Solutions. Vaccine, 35, 2217-2223. https://doi.org/10.1016/j.vaccine.2016.08.045
[16]
Prosser, W., Sagar, K., Seidel, M. and Alva, S. (2022) Ensuring Vaccine Potency and Availability: How Evidence Shaped Gavi’s Immunization Supply Chain Strategy. BMC Health Services Research, 22, Article No. 1237. https://doi.org/10.1186/s12913-022-08616-9
[17]
Lydon, P., Gandhi, G., Vandelaer, J. and Okwo-Bele, J. (2014) Health System Cost of Delivering Routine Vaccination in Low-and Lower-Middle Income Countries: What Is Needed over the Next Decade? Bulletin of the World Health Organization, 92, 382-384. https://doi.org/10.2471/blt.13.130146
[18]
Feyisa, D. (2021) Cold Chain Maintenance and Vaccine Stock Management Practices at Public Health Centers Providing Child Immunization Services in Jimma Zone, Oromia Regional State, Ethiopia: Multi-Centered, Mixed Method Approach. Pediatric Health, Medicine and Therapeutics, 12, 359-372. https://doi.org/10.2147/phmt.s312039